CLINICAL_TRIALS trial_result · 2013-07-18

Clinical Trial Update: Effects of Neupro on Cardiovascular Observations in Patients With Restless Legs Syndrome [Phase 4]

Phase 4 trial evaluating cardiovascular effects of Neupro (rotigotine) in patients with Restless Legs Syndrome; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: UCB BIOSCIENCES GmbH | Conditions: Restless Legs Syndrome | Phase 4 | Status: COMPLETED | Results posted: 2013-07-18